Of the 344 participants that initiated HAART, 316 (91.9%) were below the treatment initiation threshold defined by a CD4 count ≤350 cells/mm3 and/or the presence of a severe HIV infection defined by a stage 3 or 4 clinical condition according to the WHO recommendations. Here, CD4 is linked to HIV infectious disease.